Dollar General
DG
Nucor
NUE
Deere
DE
4
Exxon Mobil
XOM
5
Steel Dynamics
STLD
US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 2.585
- -0.105-3.90%
Trading Feb 18 12:05 ET
190.34MMarket Cap-17.23P/E (TTM)
2.650High2.550Low434.43KVolume2.650Open2.690Pre Close1.13MTurnover0.79%Turnover Ratio28.72P/E (Static)73.63MShares2.76052wk High5.86P/B141.53MFloat Cap0.82152wk Low--Dividend TTM54.75MShs Float1037.500Historical High--Div YieldTTM3.72%Amplitude0.700Historical Low2.596Avg Price1Lot Size
Protalix Biotherapeutics Key Stats
EPS
According to the latest financial report of Protalix Biotherapeutics, the latest earnings per share (TTM) for the company is 0.03. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Protalix Biotherapeutics's free cash flow? The latest report shows it as 4.02M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Protalix Biotherapeutics shows that the company's current ratio is 1.98, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Protalix Biotherapeutics, the quick ratio is 1.22, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Protalix Biotherapeutics? The latest ROE figure is 10.61%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Protalix Biotherapeutics, the total asset return on investment (ROA) is 4.23%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Protalix Biotherapeutics's latest financial report to see how their gross margin is doing - currently at 53.37%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Protalix Biotherapeutics, the net profit margin is 18.02%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.
Unlock Now